Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients

Hidekazu Tomimoto, Ichiro Akiguchi, Toshihiko Suenaga, Masaki Nishimura, Hideaki Wakita, Shinichi Nakamura, Jun Kimura

研究成果: Article

140 引用 (Scopus)

抄録

Background and Purpose: The underlying cause of white-matter lesions, which are frequent findings in cerebrovascular disease (CVD) and Alzheimer's disease (AD), remains uncertain. We performed immunohistochemical analysis of serum protein extravasation to investigate the function of the blood-brain barrier in white-matter lesions. Methods: White-matter lesions were estimated by use of Kluver-Barrera staining in patients diagnosed clinicopathologically as having ischemic CVD (n=14) and AD (n=12) and from nonneurological control subjects (n=6). Axonal damages were investigated by use of immunohistochemistry for amyloid protein precursor. Alteration of the blood- brain barrier was examined with fibrinogen and immunoglobulins used as markers. The numbers of HLA-DR-positive microglia and glial fibrillary acidic protein-positive astroglia were examined comparatively. Results: White- matter lesions were graded as normal (grade 0) in 14 of the 32 cases (44%), slight (grade I) in 10 cases (31%), moderate (grade II) in 6 cases (19%), and severe (grade III) in 2 cases (6%). Amyloid precursor protein was accumulated most frequently in grade II white-matter lesions. Immunohistochemistry for serum proteins labeled astroglial cell bodies and their processes, which seemed to have sequestered extravasated proteins. The groups with detectable white-matter lesions had significantly higher grading scores for fibrinogen and immunoglobulins than the control group (P<.05). Although the higher scores for serum protein extravasation were statistically significant in ischemic CVD cases (P<.05), there was no significant increase in AD cases. Activated microglia and astroglia were more numerous in the groups with white-matter lesions in both ischemic CVD and AD cases, although this increase in the number of astroglia was not evident in regions with clasmatodendrosis. Conclusions: Dysfunction of the blood-brain barrier is more prominent in white-matter lesions seen in ischemic CVD than in AD and may have a role in the pathogenesis of cerebrovascular white-matter lesions.

元の言語English
ページ(範囲)2069-2074
ページ数6
ジャーナルStroke
27
発行部数11
DOI
出版物ステータスPublished - 01-01-1996

Fingerprint

Cerebrovascular Disorders
Blood-Brain Barrier
Neuroglia
Alzheimer Disease
Astrocytes
Blood Proteins
Amyloid beta-Protein Precursor
Microglia
Fibrinogen
Immunoglobulins
Immunohistochemistry
White Matter
Glial Fibrillary Acidic Protein
HLA-DR Antigens
Staining and Labeling
Control Groups

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialised Nursing

これを引用

Tomimoto, Hidekazu ; Akiguchi, Ichiro ; Suenaga, Toshihiko ; Nishimura, Masaki ; Wakita, Hideaki ; Nakamura, Shinichi ; Kimura, Jun. / Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. :: Stroke. 1996 ; 巻 27, 番号 11. pp. 2069-2074.
@article{d87bdaf184af41f9a094be2e1363acfe,
title = "Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients",
abstract = "Background and Purpose: The underlying cause of white-matter lesions, which are frequent findings in cerebrovascular disease (CVD) and Alzheimer's disease (AD), remains uncertain. We performed immunohistochemical analysis of serum protein extravasation to investigate the function of the blood-brain barrier in white-matter lesions. Methods: White-matter lesions were estimated by use of Kluver-Barrera staining in patients diagnosed clinicopathologically as having ischemic CVD (n=14) and AD (n=12) and from nonneurological control subjects (n=6). Axonal damages were investigated by use of immunohistochemistry for amyloid protein precursor. Alteration of the blood- brain barrier was examined with fibrinogen and immunoglobulins used as markers. The numbers of HLA-DR-positive microglia and glial fibrillary acidic protein-positive astroglia were examined comparatively. Results: White- matter lesions were graded as normal (grade 0) in 14 of the 32 cases (44{\%}), slight (grade I) in 10 cases (31{\%}), moderate (grade II) in 6 cases (19{\%}), and severe (grade III) in 2 cases (6{\%}). Amyloid precursor protein was accumulated most frequently in grade II white-matter lesions. Immunohistochemistry for serum proteins labeled astroglial cell bodies and their processes, which seemed to have sequestered extravasated proteins. The groups with detectable white-matter lesions had significantly higher grading scores for fibrinogen and immunoglobulins than the control group (P<.05). Although the higher scores for serum protein extravasation were statistically significant in ischemic CVD cases (P<.05), there was no significant increase in AD cases. Activated microglia and astroglia were more numerous in the groups with white-matter lesions in both ischemic CVD and AD cases, although this increase in the number of astroglia was not evident in regions with clasmatodendrosis. Conclusions: Dysfunction of the blood-brain barrier is more prominent in white-matter lesions seen in ischemic CVD than in AD and may have a role in the pathogenesis of cerebrovascular white-matter lesions.",
author = "Hidekazu Tomimoto and Ichiro Akiguchi and Toshihiko Suenaga and Masaki Nishimura and Hideaki Wakita and Shinichi Nakamura and Jun Kimura",
year = "1996",
month = "1",
day = "1",
doi = "10.1161/01.STR.27.11.2069",
language = "English",
volume = "27",
pages = "2069--2074",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. / Tomimoto, Hidekazu; Akiguchi, Ichiro; Suenaga, Toshihiko; Nishimura, Masaki; Wakita, Hideaki; Nakamura, Shinichi; Kimura, Jun.

:: Stroke, 巻 27, 番号 11, 01.01.1996, p. 2069-2074.

研究成果: Article

TY - JOUR

T1 - Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients

AU - Tomimoto, Hidekazu

AU - Akiguchi, Ichiro

AU - Suenaga, Toshihiko

AU - Nishimura, Masaki

AU - Wakita, Hideaki

AU - Nakamura, Shinichi

AU - Kimura, Jun

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Background and Purpose: The underlying cause of white-matter lesions, which are frequent findings in cerebrovascular disease (CVD) and Alzheimer's disease (AD), remains uncertain. We performed immunohistochemical analysis of serum protein extravasation to investigate the function of the blood-brain barrier in white-matter lesions. Methods: White-matter lesions were estimated by use of Kluver-Barrera staining in patients diagnosed clinicopathologically as having ischemic CVD (n=14) and AD (n=12) and from nonneurological control subjects (n=6). Axonal damages were investigated by use of immunohistochemistry for amyloid protein precursor. Alteration of the blood- brain barrier was examined with fibrinogen and immunoglobulins used as markers. The numbers of HLA-DR-positive microglia and glial fibrillary acidic protein-positive astroglia were examined comparatively. Results: White- matter lesions were graded as normal (grade 0) in 14 of the 32 cases (44%), slight (grade I) in 10 cases (31%), moderate (grade II) in 6 cases (19%), and severe (grade III) in 2 cases (6%). Amyloid precursor protein was accumulated most frequently in grade II white-matter lesions. Immunohistochemistry for serum proteins labeled astroglial cell bodies and their processes, which seemed to have sequestered extravasated proteins. The groups with detectable white-matter lesions had significantly higher grading scores for fibrinogen and immunoglobulins than the control group (P<.05). Although the higher scores for serum protein extravasation were statistically significant in ischemic CVD cases (P<.05), there was no significant increase in AD cases. Activated microglia and astroglia were more numerous in the groups with white-matter lesions in both ischemic CVD and AD cases, although this increase in the number of astroglia was not evident in regions with clasmatodendrosis. Conclusions: Dysfunction of the blood-brain barrier is more prominent in white-matter lesions seen in ischemic CVD than in AD and may have a role in the pathogenesis of cerebrovascular white-matter lesions.

AB - Background and Purpose: The underlying cause of white-matter lesions, which are frequent findings in cerebrovascular disease (CVD) and Alzheimer's disease (AD), remains uncertain. We performed immunohistochemical analysis of serum protein extravasation to investigate the function of the blood-brain barrier in white-matter lesions. Methods: White-matter lesions were estimated by use of Kluver-Barrera staining in patients diagnosed clinicopathologically as having ischemic CVD (n=14) and AD (n=12) and from nonneurological control subjects (n=6). Axonal damages were investigated by use of immunohistochemistry for amyloid protein precursor. Alteration of the blood- brain barrier was examined with fibrinogen and immunoglobulins used as markers. The numbers of HLA-DR-positive microglia and glial fibrillary acidic protein-positive astroglia were examined comparatively. Results: White- matter lesions were graded as normal (grade 0) in 14 of the 32 cases (44%), slight (grade I) in 10 cases (31%), moderate (grade II) in 6 cases (19%), and severe (grade III) in 2 cases (6%). Amyloid precursor protein was accumulated most frequently in grade II white-matter lesions. Immunohistochemistry for serum proteins labeled astroglial cell bodies and their processes, which seemed to have sequestered extravasated proteins. The groups with detectable white-matter lesions had significantly higher grading scores for fibrinogen and immunoglobulins than the control group (P<.05). Although the higher scores for serum protein extravasation were statistically significant in ischemic CVD cases (P<.05), there was no significant increase in AD cases. Activated microglia and astroglia were more numerous in the groups with white-matter lesions in both ischemic CVD and AD cases, although this increase in the number of astroglia was not evident in regions with clasmatodendrosis. Conclusions: Dysfunction of the blood-brain barrier is more prominent in white-matter lesions seen in ischemic CVD than in AD and may have a role in the pathogenesis of cerebrovascular white-matter lesions.

UR - http://www.scopus.com/inward/record.url?scp=0029804231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029804231&partnerID=8YFLogxK

U2 - 10.1161/01.STR.27.11.2069

DO - 10.1161/01.STR.27.11.2069

M3 - Article

C2 - 8898818

AN - SCOPUS:0029804231

VL - 27

SP - 2069

EP - 2074

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 11

ER -